catechin and Sarcoma
catechin has been researched along with Sarcoma in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kalinovsky, T; Monterrey, J; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Becerikli, M; Behr, B; Daigeler, A; Harati, A; Harati, K; Hirsch, T; Jacobsen, F; Lehnhardt, M; Renner, M; Wallner, C | 1 |
| Jin, XF; Liu, Q; Ran, ZH; Tong, JL; Xiao, SD; Xu, Q; Xu, XT; Yang, CH | 1 |
| Banerjee, S; Das, S; Manna, S; Mukherjee, S; Panda, CK | 1 |
Other Studies
5 other study(ies) available for catechin and Sarcoma
| Article | Year |
|---|---|
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Carcinogens; Catechin; Cell Line, Tumor; Chondrosarcoma; Dactinomycin; Dexamethasone; Doxycycline; Fibrosarcoma; Humans; Interleukin-1beta; Lipopolysaccharides; Liposarcoma; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Sarcoma; Sarcoma, Synovial; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Necrosis Factor-alpha | 2013 |
In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Topics: Catechin; Cell Line, Tumor; Child; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Osteosarcoma; Pediatrics; Rhabdomyosarcoma; Sarcoma; Tumor Necrosis Factor-alpha | 2014 |
Anti‑proliferative activity of epigallocatechin‑3‑gallate and silibinin on soft tissue sarcoma cells.
Topics: Antineoplastic Agents; Antioxidants; Catechin; Cell Line, Tumor; Cell Proliferation; Fibrosarcoma; Humans; Liposarcoma; Sarcoma; Sarcoma, Synovial; Silybin; Silymarin | 2017 |
Chemopreventive effect of epigallocatechin-3-gallate (EGCG) and folic acid on the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced gastrointestinal cancer in rat model.
Topics: Adenocarcinoma; Administration, Oral; Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Folic Acid; Gastrointestinal Neoplasms; Hematinics; Male; Methylnitronitrosoguanidine; Rats; Rats, Wistar; Sarcoma; Treatment Outcome | 2011 |
Epigallocatechin gallate induced apoptosis in Sarcoma180 cells in vivo: mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expression.
Topics: Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Catechin; Cell Cycle; Cell Proliferation; Gene Expression Regulation, Neoplastic; In Situ Nick-End Labeling; Injections, Intraperitoneal; Mice; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; RNA, Messenger; RNA, Neoplasm; RNA, Small Nuclear; Sarcoma; Tumor Suppressor Protein p53 | 2006 |